Molecular Imaging Techniques in Body Imaging
Authors:
- John M. HoffmanJHJohn M. Hoffman
- Robert J. HerfkensRHRobert J. Herfkens
- R. Brooke JeffreyRJR. Brooke Jeffrey
- Andrew QuonAQAndrew Quon
- Sanjiv S. GambhirSGSanjiv S. Gambhir
- 1 November 2007
- journal article
- review article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 245 (2) , 333-356
Abstract
Molecular imaging of the body involves new techniques to image cellular biochemical processes, which results in studies with high sensitivity, specificity, and signal-to-background. The most prevalently used molecular imaging technique in body imaging is currently fluorine 18 fluorodeoxyglucose (FDG) positron emission tomography (PET). FDG PET has become the method of choice for the staging and restaging of many of the most common cancers, including lymphoma, lung cancer, breast cancer, and colorectal cancer. FDG PET has also become extremely valuable in monitoring the response to therapeutic drugs in many cancers. New PET agents, such as fluorothymidine and acetate, have also shown promise in the evaluation of response to therapy and in the staging of prostate cancer. Magnetic resonance (MR) spectroscopy has shown promise in the evaluation of prostate cancer. Breast cancer evaluation benefits from advances in spectroscopic imaging and contrast-enhanced kinetic evaluation of vascular permeability, which is altered in neoplastic processes because of release of angiogenic factors. Superparamagnetic iron oxide (SPIO) particles represent the first of an expanding line of MR contrast agents that target specific cellular processes. SPIO particles have also been used in the evaluation of the cirrhotic liver and at MR lymphangiography.Keywords
This publication has 254 references indexed in Scilit:
- Positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancerInternational Journal of Clinical Oncology, 2005
- Detection of recurrent cervical cancer by whole-body FDG PET scan in asymptomatic and symptomatic womenGynecologic Oncology, 2004
- Contribution of 18fluoro-deoxyglucose positron emission tomography to the work-up of patients with fever of unknown originEuropean Journal of Internal Medicine, 2004
- Clinical risk score correlates with yield of PET scan in patients with colorectal hepatic metastasesJournal of Gastrointestinal Surgery, 2004
- Supramolecular Adducts between Poly‐L‐arginine and [TmIIIdotp]: A Route to Sensitivity‐Enhanced Magnetic Resonance Imaging–Chemical Exchange Saturation Transfer AgentsAngewandte Chemie International Edition, 2003
- Improved molecular imaging contrast agent for detection of human thrombusMagnetic Resonance in Medicine, 2003
- Measuring [18F]FDG uptake in breast cancer during chemotherapy: comparison of analytical methodsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- MR imaging of mediastinal lymph nodes: Evaluation using a superparamagnetic contrast agentJournal of Magnetic Resonance Imaging, 2000
- Multicenter clinical trial of ultrasmall superparamagnetic iron oxide in the evaluation of mediastinal lymph nodes in patients with primary lung carcinomaJournal of Magnetic Resonance Imaging, 1999
- 18F-fluorodeoxyglucose positron emission tomography and the prognosis of patients with pancreatic adenocarcinomaCancer, 1997